1. Home
  2. BVS vs GAIN Comparison

BVS vs GAIN Comparison

Compare BVS & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • GAIN
  • Stock Information
  • Founded
  • BVS 2011
  • GAIN 2005
  • Country
  • BVS United States
  • GAIN United States
  • Employees
  • BVS N/A
  • GAIN N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GAIN Finance: Consumer Services
  • Sector
  • BVS Health Care
  • GAIN Finance
  • Exchange
  • BVS Nasdaq
  • GAIN Nasdaq
  • Market Cap
  • BVS 448.8M
  • GAIN 522.8M
  • IPO Year
  • BVS 2021
  • GAIN 2005
  • Fundamental
  • Price
  • BVS $6.64
  • GAIN $13.42
  • Analyst Decision
  • BVS Strong Buy
  • GAIN Buy
  • Analyst Count
  • BVS 5
  • GAIN 2
  • Target Price
  • BVS $14.40
  • GAIN $14.00
  • AVG Volume (30 Days)
  • BVS 294.3K
  • GAIN 193.2K
  • Earning Date
  • BVS 11-04-2025
  • GAIN 11-06-2025
  • Dividend Yield
  • BVS N/A
  • GAIN 16.34%
  • EPS Growth
  • BVS N/A
  • GAIN 8.96
  • EPS
  • BVS 0.03
  • GAIN 2.16
  • Revenue
  • BVS $564,142,000.00
  • GAIN $95,028,000.00
  • Revenue This Year
  • BVS N/A
  • GAIN $6.54
  • Revenue Next Year
  • BVS $6.88
  • GAIN $4.49
  • P/E Ratio
  • BVS $240.50
  • GAIN $6.22
  • Revenue Growth
  • BVS 5.08
  • GAIN 6.55
  • 52 Week Low
  • BVS $5.81
  • GAIN $11.42
  • 52 Week High
  • BVS $14.38
  • GAIN $15.34
  • Technical
  • Relative Strength Index (RSI)
  • BVS 42.20
  • GAIN 26.80
  • Support Level
  • BVS $6.46
  • GAIN $13.70
  • Resistance Level
  • BVS $7.14
  • GAIN $14.02
  • Average True Range (ATR)
  • BVS 0.26
  • GAIN 0.19
  • MACD
  • BVS -0.02
  • GAIN -0.03
  • Stochastic Oscillator
  • BVS 34.67
  • GAIN 2.85

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

Share on Social Networks: